Logo image of BWAY

BRAINSWAY LTD-ADR (BWAY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BWAY - US10501L1061 - ADR

15.025 USD
+0.13 (+0.91%)
Last: 11/24/2025, 4:30:01 PM
Fundamental Rating

6

BWAY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. BWAY is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BWAY has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings could make BWAY a good candidate for value and growth investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BWAY was profitable.
BWAY had a positive operating cash flow in the past year.
BWAY had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BWAY reported negative operating cash flow in multiple years.
BWAY Yearly Net Income VS EBIT VS OCF VS FCFBWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

The Return On Assets of BWAY (4.79%) is better than 80.85% of its industry peers.
Looking at the Return On Equity, with a value of 7.84%, BWAY belongs to the top of the industry, outperforming 81.91% of the companies in the same industry.
BWAY has a better Return On Invested Capital (1.83%) than 69.15% of its industry peers.
Industry RankSector Rank
ROA 4.79%
ROE 7.84%
ROIC 1.83%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
BWAY Yearly ROA, ROE, ROICBWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

BWAY has a better Profit Margin (11.60%) than 86.17% of its industry peers.
With a decent Operating Margin value of 4.05%, BWAY is doing good in the industry, outperforming 68.62% of the companies in the same industry.
BWAY's Gross Margin of 74.52% is amongst the best of the industry. BWAY outperforms 85.11% of its industry peers.
In the last couple of years the Gross Margin of BWAY has remained more or less at the same level.
Industry RankSector Rank
OM 4.05%
PM (TTM) 11.6%
GM 74.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
BWAY Yearly Profit, Operating, Gross MarginsBWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BWAY is destroying value.
BWAY has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BWAY has more shares outstanding
Compared to 1 year ago, BWAY has a worse debt to assets ratio.
BWAY Yearly Shares OutstandingBWAY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BWAY Yearly Total Debt VS Total AssetsBWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 3.96 indicates that BWAY is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.96, BWAY is in the better half of the industry, outperforming 73.40% of the companies in the same industry.
The Debt to FCF ratio of BWAY is 0.33, which is an excellent value as it means it would take BWAY, only 0.33 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.33, BWAY belongs to the best of the industry, outperforming 92.55% of the companies in the same industry.
A Debt/Equity ratio of 0.08 indicates that BWAY is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.08, BWAY is in the better half of the industry, outperforming 65.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.33
Altman-Z 3.96
ROIC/WACC0.21
WACC8.56%
BWAY Yearly LT Debt VS Equity VS FCFBWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 3.51 indicates that BWAY has no problem at all paying its short term obligations.
BWAY has a better Current ratio (3.51) than 63.83% of its industry peers.
A Quick Ratio of 3.34 indicates that BWAY has no problem at all paying its short term obligations.
BWAY has a Quick ratio of 3.34. This is in the better half of the industry: BWAY outperforms 71.28% of its industry peers.
Industry RankSector Rank
Current Ratio 3.51
Quick Ratio 3.34
BWAY Yearly Current Assets VS Current LiabilitesBWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

7

3. Growth

3.1 Past

BWAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 260.14%, which is quite impressive.
Looking at the last year, BWAY shows a very strong growth in Revenue. The Revenue has grown by 29.04%.
BWAY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.17% yearly.
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
Revenue 1Y (TTM)29.04%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%

3.2 Future

The Earnings Per Share is expected to grow by 53.27% on average over the next years. This is a very strong growth
BWAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.29% yearly.
EPS Next Y58.83%
EPS Next 2Y54.54%
EPS Next 3Y53.27%
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2Y18.5%
Revenue Next 3Y19.29%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BWAY Yearly Revenue VS EstimatesBWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
BWAY Yearly EPS VS EstimatesBWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.18, which indicates a correct valuation of BWAY.
Based on the Price/Earnings ratio, BWAY is valued cheaply inside the industry as 88.83% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 25.47. BWAY is valued slightly cheaper when compared to this.
BWAY is valuated reasonably with a Price/Forward Earnings ratio of 9.96.
93.09% of the companies in the same industry are more expensive than BWAY, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of BWAY to the average of the S&P500 Index (34.42), we can say BWAY is valued rather cheaply.
Industry RankSector Rank
PE 13.18
Fwd PE 9.96
BWAY Price Earnings VS Forward Price EarningsBWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

65.96% of the companies in the same industry are more expensive than BWAY, based on the Enterprise Value to EBITDA ratio.
BWAY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BWAY is cheaper than 92.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.25
EV/EBITDA 52.91
BWAY Per share dataBWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BWAY's earnings are expected to grow with 53.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y54.54%
EPS Next 3Y53.27%

0

5. Dividend

5.1 Amount

No dividends for BWAY!.
Industry RankSector Rank
Dividend Yield N/A

BRAINSWAY LTD-ADR

NASDAQ:BWAY (11/24/2025, 4:30:01 PM)

15.025

+0.13 (+0.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11 2025-11-11/dmh
Earnings (Next)03-09 2026-03-09/bmo
Inst Owners5.13%
Inst Owner Change-5.42%
Ins Owners16.62%
Ins Owner ChangeN/A
Market Cap285.53M
Revenue(TTM)41.02M
Net Income(TTM)5.34M
Analysts85.71
Price Target0.12 (-99.2%)
Short Float %0.46%
Short Ratio1.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)36.24%
Min EPS beat(2)-22.64%
Max EPS beat(2)95.12%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.21%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)-0.08%
Revenue beat(4)2
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.15%
Revenue beat(8)5
Avg Revenue beat(8)0.76%
Revenue beat(12)6
Avg Revenue beat(12)-18.08%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.61%
PT rev (3m)20.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.63%
EPS NY rev (1m)0%
EPS NY rev (3m)-27.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-25.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.88%
Valuation
Industry RankSector Rank
PE 13.18
Fwd PE 9.96
P/S 6.2
P/FCF 15.25
P/OCF 12.33
P/B 4.19
P/tB 4.19
EV/EBITDA 52.91
EPS(TTM)1.14
EY7.59%
EPS(NY)1.51
Fwd EY10.04%
FCF(TTM)0.99
FCFY6.56%
OCF(TTM)1.22
OCFY8.11%
SpS2.43
BVpS3.59
TBVpS3.59
PEG (NY)0.22
PEG (5Y)N/A
Graham Number9.59
Profitability
Industry RankSector Rank
ROA 4.79%
ROE 7.84%
ROCE 2.17%
ROIC 1.83%
ROICexc 19.56%
ROICexgc 19.56%
OM 4.05%
PM (TTM) 11.6%
GM 74.52%
FCFM 40.64%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.33
Debt/EBITDA 1.37
Cap/Depr 229.33%
Cap/Sales 9.62%
Interest Coverage 11.81
Cash Conversion 609.66%
Profit Quality 350.45%
Current Ratio 3.51
Quick Ratio 3.34
Altman-Z 3.96
F-Score4
WACC8.56%
ROIC/WACC0.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
EPS Next Y58.83%
EPS Next 2Y54.54%
EPS Next 3Y53.27%
EPS Next 5YN/A
Revenue 1Y (TTM)29.04%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%
Revenue Next Year15%
Revenue Next 2Y18.5%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y155.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.13%
EBIT Next 3Y41.44%
EBIT Next 5YN/A
FCF growth 1Y321.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y429.93%
OCF growth 3Y127.03%
OCF growth 5YN/A

BRAINSWAY LTD-ADR / BWAY FAQ

What is the fundamental rating for BWAY stock?

ChartMill assigns a fundamental rating of 6 / 10 to BWAY.


What is the valuation status for BWAY stock?

ChartMill assigns a valuation rating of 8 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.


How profitable is BRAINSWAY LTD-ADR (BWAY) stock?

BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.


What is the valuation of BRAINSWAY LTD-ADR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BRAINSWAY LTD-ADR (BWAY) is 13.18 and the Price/Book (PB) ratio is 4.19.